⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Medfiles and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Medfiles
↗Kuopio, Finland
Medfiles is a well-established, full-service Contract Research Organization (CRO) founded in 1987 and headquartered in Kuopio, Finland. The company provides comprehensive support for the pharmaceutical, biotechnology, medical device, food, and veterinary industries, offering services that span the entire product lifecycle, including R&D, clinical trials (Phase I-IV), regulatory affairs, pharmacovigilance, and analytical services.
Positioned as a 'one-stop-shop,' Medfiles supports clients ranging from early-stage start-ups to global, stock-listed companies. While maintaining a strong presence in the Nordic and Baltic regions, the company operates through an extensive international partner network to facilitate global market access and compliance.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:1987
Ownership:subsidiary
Status:operating
FUNDING
Investors:Canelco Capital, Sentica Partners
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Medical Devices, IVD
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:WDB Holdings
Acquired By:WDB Holdings (2017-03-01)
Key Partnerships:LINK Medical (Nordic/Baltic regulatory and clinical services partnership)
COMPETITION
Position:Niche Player
Competitors:IQVIA, ICON plc, Medpace, Biomapas, Curia
LEADERSHIP
Key Executives:
Norifumi Ninokata - Management
LINKS
Website:medfiles.eu
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Medfiles. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.